Please scroll down for Important Safety Information and Prescribing Information.

Victoza® is a non-insulin medicine that—along with diet and exercise—can help control type 2 diabetes. Victoza® starts to lower blood sugar in as soon as 2 weeks, lowers A1C, and has been shown to keep it down in a 2-year medical study. It comes in a prefilled pen you use just once a day, any time, so it fits into your busy life. While not a weight-loss product, Victoza® may help you lose some weight. Victoza® is covered by most major health care plans and if eligible, you can pay no more than $25 on your prescription co-pay.

What is Victoza®?

Victoza® is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes, and should be used along with diet and exercise.

Victoza® is not recommended as the first choice of medicine for treating diabetes.

It is not known if Victoza® can be used in people who have had pancreatitis.

Victoza® is not a substitute for insulin and is not for use in people with type 1 diabetes or people with diabetic ketoacidosis.

It is not known if Victoza® can be used with mealtime insulin.

It is not known if Victoza® is safe and effective for use in children.

Important Safety Information

What is the most important information I should know about Victoza®?
Victoza® may cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza® and medicines that work like Victoza® caused thyroid tumors, including thyroid cancer. It is not known if Victoza® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Victoza®?
Do not use Victoza® if:

you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

you are allergic to liraglutide or any of the ingredients in Victoza®.

What should I tell my health care provider before using Victoza®?
Before using Victoza®, tell your health care provider if you:

have or have had problems with your pancreas, kidneys, or liver.

have any other medical conditions or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.

are pregnant or breastfeeding or plan to become pregnant or breastfeed. Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

How should I use Victoza®?

Do not mix insulin and Victoza® together in the same injection.

You may give an injection of Victoza® and insulin in the same body area (such as your stomach area), but not right next to each other.

Do not share your Victoza® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

What are the possible side effects of Victoza®?
Victoza® may cause serious side effects, including:

inflammation of your pancreas (pancreatitis). Stop using Victoza® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Victoza® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.

kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse.

serious allergic reactions. Stop using Victoza® and get medical help right away if you have any symptoms of a serious allergic reaction including itching, rash, or difficulty breathing.

The most common side effects of Victoza® may include headache, nausea, diarrhea, vomiting, and anti-liraglutide antibodies in your blood.

Please scroll down for Important Safety Information and Prescribing Information.

Levemir® is a long-acting insulin analog that can help control high blood sugar for up to 24 hours in adults with type 1 or type 2 diabetes. Levemir® can be dosed once or twice daily and is the first and only long-acting insulin analog that has been approved for use in children with type 1 diabetes as young as 2 years of age. Levemir® is also the first and only man-made long-acting insulin to receive a Pregnancy Category B classification. Levemir® is available in 10 mL vials, and in FlexTouch®. Levemir® FlexTouch® is the only prefilled insulin pen with no push-button extension and is covered by most health insurance plans and Medicare part D plans. Ask your doctor if Levemir® FlexTouch® is right for you. For more information on Levemir® FlexTouch® and a money-saving offer, please visit www.levemir.com.

Select a valid page path.

Selected Important Safety Information

Do not share your Levemir® FlexTouch® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take Levemir®?
Do not take Levemir® if:

you have an allergy to Levemir® or any of the ingredients in Levemir®.

Please scroll down for Important Safety Information and Prescribing Information.

NovoLog® Mix 70/30 is a premixed insulin that works in 2 different ways to lower your A1C. It controls blood sugar in between meals for up to 24 hours and treats blood sugar spikes when you eat. NovoLog® Mix 70/30 is available in 10 mL vials, and in FlexPen®, a discreet, prefilled, dial-a-dose insulin pen. For more information, visit www.novologmix70-30.com.

Select a valid page path.

Selected Important Safety Information

Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not use NovoLog® Mix 70/30?

Do not use NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

How should I take NovoLog® Mix 70/30?

NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal.

Inject NovoLog® Mix 70/30 under the skin of your stomach area, upper arms, buttocks, or thighs, but never into a vein or muscle.

Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump.

Do not change your dose or type of insulin unless you are told to by your health care provider.

Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them.

Indications and Usage

NovoLog® Mix 70/30 is a man-made insulin used to control high blood sugar in adults with diabetes mellitus.

It is not known if NovoLog® Mix 70/30 is safe or effective in children.

Important Safety Information

Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not use NovoLog® Mix 70/30?

Do not use NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

What should I tell my health care provider before taking NovoLog® Mix 70/30?

About all of your medical conditions, including liver, kidney, or heart problems.

If you are pregnant, breastfeeding, or plan to do either.

About all prescription and nonprescription medicines you take, including supplements, as your dose may need to change.

How should I take NovoLog® Mix 70/30?

NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal.

Inject NovoLog® Mix 70/30 under the skin of your stomach area, upper arms, buttocks, or thighs, but never into a vein or muscle.

Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump.

Do not change your dose or type of insulin unless you are told to by your health care provider.

Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them.

Be careful when driving a car or operating machinery. You may have difficulty concentrating or reacting if you have low blood sugar. Talk to your health care provider if you often have low blood sugar or no warning signs of low blood sugar.

What are the possible side effects of NovoLog® Mix 70/30?

Low blood sugar, including when too much is taken. Some symptoms include sweating, shakiness, confusion, and headache. Severe low blood sugar can cause unconsciousness, seizures, and death.

Serious allergic reactions may occur. Get medical help right away, if you develop a rash over your whole body, have trouble breathing, a fast heartbeat, or sweating.

Other side effects include low potassium in your blood, injection site reactions (like redness, swelling, and itching), skin thickening or pits at the injection site, weight gain, swelling of your hands and feet, if taken with thiazolidinediones (TZDs) possible heart failure, and vision changes.

People are unique and have different needs when it comes to managing diabetes. That’s why Cornerstones4Care® offers a free, personalized action plan with resources that you can access 24/7. View content tailored to where you are in your diabetes journey, and get the right support at the right time. You set your own preferences, so you can go at your own pace and focus on what interests you most. With Cornerstones4Care®, you’re empowered to take part in a diabetes care plan made just for you.

Your plan will be based on the 4 cornerstones that provide the foundation for solid diabetes management:

Healthy eating—Create your own menu of tasty, diabetes-friendly dishes from a wide selection of recipes

Being active—Find creative ways to get the physical activity you need. Even small changes can make a big difference!

Medicine—Learn more about diabetes medications, and keep track of the ones you take

Tracking—Checking your blood sugar levels on a regular basis helps identify patterns, and better informs the members of your diabetes care team so they can make any necessary changes in your plan

Cornerstones4Care® is brought to you by Novo Nordisk, who has been passionate about helping people with diabetes since 1923. We are dedicated to helping you manage your diabetes, your way, with the personalized resources and services you can find in Cornerstones4Care®—a diabetes support program built around you.

Select a valid page path.

Selected Important Safety Information

What is the most important information I should know about Victoza®?
Victoza® can cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats and mice, Victoza® and medicines that work like Victoza® caused thyroid tumors, including thyroid cancer. It is not known if Victoza® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Who should not use Victoza®?
Do not use Victoza® if:

you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

you are allergic to liraglutide or any of the ingredients in Victoza®.

Most people with type 1 diabetes and some people with type 2 diabetes take mealtime insulin to control their diabetes.

As you may have already figured out, mealtime insulin is insulin taken with meals. Of course, take your dose as instructed by your health care team. Mealtime insulin is also known as fast-acting or bolus insulin. NovoLog® is a fast-acting mealtime insulin that is used in addition to a long-acting (basal) insulin. For many people with type 1 diabetes, NovoLog® is used in an insulin pump to provide both the necessary basal and bolus insulin coverage. Learn more about using NovoLog® in a pump by clicking here.

While long-acting basal insulin helps you control blood sugar between meals and during sleep, it may not be enough to help your body handle blood sugar spikes that happen after eating.

That’s why your health care provider may have prescribed a mealtime insulin for you. It may give you the extra help you need to manage blood sugar spikes that happen when you eat. It works quickly to help control blood sugar at mealtime.

Fast-acting insulin analogs go to work quickly. So, you will need to eat a meal within 5 to 10 minutes after taking NovoLog®.

Managing your blood sugar with mealtime insulin can help lower your A1C (a measure of blood sugar control over 2 to 3 months) when taken with a long-acting insulin. And, if you need to add mealtime insulin to your diabetes care plan, you are not alone. In fact, in 1 study of people with type 2 diabetes, after 1 year of long-acting therapy, 8 out of 10 people were not at A1C goal of less than 6.5% and needed to add mealtime insulin to help them reach their target A1C goal.

Remember, adding mealtime insulin doesn’t mean you did anything wrong in your diabetes care. It just means that you now need another medicine to help get to your A1C goal.

If you need help talking with your doctor about adding NovoLog® mealtime insulin to your care plan, you can use our Doctor Discussion Guideto help organize your thoughts.

What Are FPG, PPG, and A1C?

It seems like just a lot of abbreviations, but actually these are important measures of your diabetes control. In fact, PPG control has a lot to do with reaching your A1C goal.

Rudy talks about enjoying food with friends while controlling portions.

Selected Important Safety Information

Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take NovoLog®?
Do not take NovoLog® if:

your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

How should I take NovoLog®?

Read the Instructions for Use and take exactly as directed.

NovoLog® is fast-acting. Eat a meal within 5 to 10 minutes after taking it.

Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them.

Do not reuse or share your needles with other people. You may give other people a serious infection, or get a serious infection from them.

Indications and Usage

What is NovoLog® (insulin aspart [rDNA origin] injection)?

NovoLog® is a man-made insulin used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.

Who should not take NovoLog®?
Do not take NovoLog® if:

your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients.

Clicking "Continue" at the bottom of this page will take you to a website to which the Novo Nordisk Privacy Policy does not apply. Links are provided as a public service and for informational purposes only. No endorsement is made or implied.